Compare 10X Genomics Inc (TXG) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.47. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Vanguard Tax Managed Fund FTSE Developed Markets ETF nearer its low. Which is the better fit depends on your goals.
| TXG | VEA | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | — |
52-Week High | $45.80 | $72.39 |
52-Week Low | $11.34 | $56.02 |
Enterprise Value | $5.02B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Vanguard Tax Managed Fund FTSE Developed Markets ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →
